George Washington University Hospital, District of Columbia
Dr. Danielle Davison is a professor of critical medicine and anesthesiology and medicine and the division chief of critical care medicine at the George Washington University. She was born in Livingston, N.J. and received a bachelor of science from Duke University. She earned her medical degree at the George Washington University School of Medicine and Health Sciences. She subsequently completed her residency in internal medicine and fellowship in critical care medicine at the George Washington University. Between residency and fellowship, Dr. Davison spent one year as the chief medical resident of the internal medicine program.
Dr. Davison has been in academic and clinical practice for over 15 years. She is currently a professor of critical care medicine and anesthesiology, the division chief of the ICU at the George Washington University hospital, and the associate fellowship program director. Prior to becoming the division chief of the ICU, she was previously the fellowship program director and clinical clerkship director for medical students in the ICU.
Special interests of research in the ICU include , acute kidney injury and medical education within the ICU.
Dr. Davison is board certified in Critical Care Medicine, and a member of the Society of Critical Care Medicine and the Association of Pulmonary and Critical Care Program Directors. Dr. Davison resides in Washington, D.C. with her husband and two children.
Platelets and the Breath of Life: Impact on Ventilation Duration After Cardiac Surgery
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure information not submitted.
Intraoperative Transfusion and 30-Day Mortality After Cardiac Surgery: A Retrospective Analysis
Sunday, March 22, 2026
11:00 AM - 12:00 PM Central Time
Disclosure information not submitted.
The Middle Ground: A Survey of Fellowship Training Practices With Midline Catheters in Critical Care
Sunday, March 22, 2026
12:15 PM - 1:15 PM Central Time
Disclosure information not submitted.
Mitochondrial-Directed Therapy in Prevention of CABG-Associated AKI: mtDNA as Early Biomarker
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure information not submitted.
The "Quiet" Effect: Superstitious Language and Code Calls in an Academic Medical Center
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure information not submitted.
Pro/Con: Thrombectomy Versus Thrombolytics for Pulmonary Embolism
Tuesday, March 24, 2026
1:30 PM - 2:15 PM Central Time
Disclosure(s): Vantive Healthcare LLC: Consulting fees or other remuneration (Ongoing)